about
Epigenetic events in liver cancer resulting from alcoholic liver diseaseS-adenosylmethionine prevents the up regulation of Toll-like receptor (TLR) signaling caused by chronic ethanol feeding in ratsUfmylation and FATylation pathways are downregulated in human alcoholic and nonalcoholic steatohepatitis, and mice fed DDC, where Mallory-Denk bodies (MDBs) formS-adenosylmethionine in liver health, injury, and cancer.Mallory-Denk Body (MDB) formation modulates Ufmylation expression epigenetically in alcoholic hepatitis (AH) and non-alcoholic steatohepatitis (NASH).IL-8 signaling is up-regulated in alcoholic hepatitis and DDC fed mice with Mallory Denk Bodies (MDBs) present.Altered regulation of miR-34a and miR-483-3p in alcoholic hepatitis and DDC fed mice.Aberrant modulation of the BRCA1 and G1/S cell cycle pathways in alcoholic hepatitis patients with Mallory Denk Bodies revealed by RNA sequencing.The role of innate immunity in the pathogenesis of preneoplasia in drug-induced chronic hepatitis based on a mouse model.Broad spectrum of hepatocyte inclusions in humans, animals, and experimental models.TLR3/4 signaling is mediated via the NFκB-CXCR4/7 pathway in human alcoholic hepatitis and non-alcoholic steatohepatitis which formed Mallory-Denk bodies.Mallory Denk Body Formation in Alcoholic Hepatitis: The Pivotal Role of Interleukin-8 Signaling.Balloon liver cells forming Mallory-Denk-bodies are progenitor cells.The immunoproteasome in steatohepatitis: its role in Mallory-Denk body formationAlcoholic liver disease - Hepatocellular carcinoma transformation.Increased expression of FAT10 in colon benign, premalignant and malignant epithelial neoplasms.Increased activity of the complement system in the liver of patients with alcoholic hepatitis.The role of Tec kinase signaling pathways in the development of Mallory Denk Bodies in balloon cells in alcoholic hepatitis.The inflammasome in alcoholic hepatitis: Its relationship with Mallory-Denk body formation.Levels of metacaspase1 and chaperones related to protein quality control in alcoholic and nonalcoholic steatohepatitis.A prospective study of the utility of plasma biomarkers to diagnose alcoholic hepatitis.
P2860
Q27024328-A3575AC6-7030-47F5-8778-C8D19EB6DD42Q28388406-F49EB7EF-8170-43DD-A593-A5BE66D94E0DQ34022720-6CCF0164-DAB1-4D80-BB13-48A7E4C9020BQ34306534-1796B1EF-4A09-40BA-8393-62C3BFD593F9Q34674178-9603F387-6650-4CA0-8F46-8E30456C40FDQ36113647-3EB31190-C02F-4777-B91D-AAA32BC650B8Q36372824-1D308623-8201-490E-9451-E42554566F6EQ36618902-7B12146B-AA0A-4692-864F-061B289B3249Q37912492-B1C9BEA6-8CD8-48C9-AF86-458747B43294Q38165139-45AB5D18-EEF6-4C87-9951-7D85B9CCFDF0Q38391018-9D4499BC-956C-404C-BE1E-6A2CC01BC18FQ39504379-925A8077-F1B3-4C3A-B0AB-7F21C940A474Q41861751-805011AA-6910-487C-AF91-D982B5CAF438Q41952815-0D56EFE2-732E-42CA-B737-BF308371E330Q42201909-CEFC5BA9-1373-4FDB-B46E-F6BBC6AE05FDQ42557738-493A90B4-1EB7-4761-8379-5462676956EAQ42565056-55A0CD6E-EE48-49F4-A045-6ADCFFBC84CAQ42777814-1208F67C-920D-4FB3-964F-3BA95F1AF500Q42918546-7F672DF5-63D5-4B77-AB5A-934DD74F8E59Q43190615-C7DFA69D-2ADE-4EB9-8FF1-2F71EB65032AQ50218188-DBBECE3A-CC8F-47B2-9057-C498A9CBAE13
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Mallory-Denk body pathogenesis revisited
@ast
Mallory-Denk body pathogenesis revisited
@en
Mallory-Denk body pathogenesis revisited
@nl
type
label
Mallory-Denk body pathogenesis revisited
@ast
Mallory-Denk body pathogenesis revisited
@en
Mallory-Denk body pathogenesis revisited
@nl
prefLabel
Mallory-Denk body pathogenesis revisited
@ast
Mallory-Denk body pathogenesis revisited
@en
Mallory-Denk body pathogenesis revisited
@nl
P2093
P2860
P356
P1476
Mallory-Denk body pathogenesis revisited
@en
P2093
Barbara A French
Joan Oliva
Samuel W French
P2860
P304
P356
10.4254/WJH.V2.I8.295
P407
P577
2010-08-27T00:00:00Z